Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer [Corrigendum]
Wang N, Gu Y, Li L, et al. J Inflamm Res. 2022;15:3477–3499. The authors have advised due to an error that occurred inadvertently at the time of figure assembly, the scratch test result of si-SDC1 MBA-MD-231 cells were wrongly placed in the position of the scratch test results of si-SORBS1...
Main Authors: | Wang N, Gu Y, Li L, Chi J, Liu X, Xiong Y, Zhong C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-09-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-development-and-validation-of-a-prognostic-classifier-base-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer
by: Wang N, et al.
Published: (2022-06-01) -
La minorité sorbe du Brandebourg vue par l’écrivain prussien Theodor Fontane (1819-1898)
by: Isabelle Solères -
Prognostic and Predictive Biomarkers in Familial Breast Cancer
by: Siddhartha Deb, et al.
Published: (2023-02-01) -
Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data
by: Tiemo S. Gerber, et al.
Published: (2021-06-01) -
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma
by: Gen Li, et al.
Published: (2024-02-01)